Related Experiment Video
Updated: Jul 28, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Inflammatory mechanisms and intervention strategies for sepsis-induced myocardial dysfunction
Yuxin Nong1, Xuebiao Wei2, Danqing Yu1
1Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Insights
Sepsis-induced myocardial dysfunction (SIMD) remains a major cause of death. Understanding the complex inflammatory mechanisms and exploring new therapies are crucial for improving patient outcomes in sepsis.
Area of Science:
- Cardiology
- Critical Care Medicine
- Immunology
Background:
- Sepsis-induced myocardial dysfunction (SIMD) is a primary cause of mortality in intensive care units.
- SIMD presents as systolic and diastolic cardiac dysfunction, with persistently high incidence and mortality rates.
- Despite decades of research, the heterogeneity of sepsis, pathogens, and host factors complicates SIMD understanding.
Purpose of the Study:
- To review the complex inflammatory mechanisms underlying sepsis-induced myocardial dysfunction.
- To explore potential novel therapeutic strategies for managing SIMD.
Main Methods:
- Literature review of recent studies on SIMD.
- Analysis of inflammatory responses in sepsis and their impact on cardiac function.
- Identification and discussion of emerging therapeutic approaches.
Main Results:
- SIMD is increasingly recognized as a multifactorial condition, not solely due to excessive inflammation.
- Inflammatory responses between the pathogen and host significantly shape SIMD development.
- Novel therapeutic strategies are being investigated to target these complex mechanisms.
Conclusions:
- A comprehensive understanding of SIMD requires considering the interplay of pathogen, host, and inflammatory factors.
- Targeting these intricate inflammatory pathways offers promising avenues for future SIMD therapies.
- Further research into novel treatments is essential to reduce the high mortality associated with SIMD.
Abstract:
Sepsis-induced myocardial dysfunction (SIMD) is the leading cause of death in patients with sepsis in the intensive care units. The main manifestations of SIMD are systolic and diastolic dysfunctions of the myocardium. Despite our initial understanding of the SIMD over the past three decades, the incidence and mortality of SIMD remain high. This may be attributed to the large degree of heterogeneity among the initiating factors, disease processes, and host states involved in SIMD. Previously, organ dysfunction caused by sepsis was thought to be an impairment brought about by an excessive inflammatory response. However, many recent studies have shown that SIMD is a consequence of a combination of factors shaped by the inflammatory responses between the pathogen and the host. In this article, we review the mechanisms of the inflammatory responses and potential novel therapeutic strategies in SIMD.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management

